Factor X Activator for Hemophilia Patients with Inhibitors: A Phase 1, First-in-Human, Multi-Center, and Open-Label Trial

被引：0
|
作者：
Liu, Wei [1 ,2 ]
Xue, Feng [1 ,2 ]
Fu, Rongfeng [1 ,2 ]
Ding, Bingjie [3 ,4 ]
Li, Mengjuan [1 ,2 ]
Sun, Ting [1 ,2 ]
Chen, Yunfei [1 ,2 ]
Liu Xiaofan [1 ,2 ]
Ju, Mankai [1 ,2 ]
Dai, Xinyue [1 ,2 ]
Wu, Quanrui [5 ]
Zhou, Zan [5 ]
Wang, Xiaomin [5 ]
Yu, Jiaojiao [5 ]
Zhou, Hu [3 ,4 ]
Yang, Renchi [1 ,2 ]
Zhang, Lei [1 ,2 ]
机构：
[1] Chinese Acad Med Sci, State Key Lab Expt Hematol, Natl Clin Res Ctr Blood Dis, Haihe Lab Cell Ecosyst,Inst Hematol, Tianjin, Peoples R China
[2] Chinese Acad Med Sci, Blood Dis Hosp, Tianjin, Peoples R China
[3] Zhengzhou Univ, Affiliated Canc Hosp, Dept Hematol, Zhengzhou, Peoples R China
[4] Zhengzhou Univ, Henan Canc Hosp, Hemostasis & Thrombosis Diagnost Engn Res Ctr Hen, Zhengzhou, Peoples R China
[5] Staidson Beijing Biopharmaceut Co Ltd, Beijing, Peoples R China
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-159948
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：8474 / 8475
页数：2
相关论文
共 50 条
  • [1] Preclinical studies of a factor X activator and a phase 1 trial for hemophilia patients with inhibitors
    Liu, Wei
    Xue, Feng
    Fu, Rongfeng
    Ding, Bingjie
    Li, Mengjuan
    Sun, Ting
    Chen, Yunfei
    Liu, Xiaofan
    Ju, Mankai
    Dai, Xinyue
    Wu, Quanrui
    Zhou, Zan
    Yu, Jiaojiao
    Wang, Xiaomin
    Zhu, Qing
    Zhou, Hu
    Yang, Renchi
    Zhang, Lei
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2023, 21 (06) : 1453 - 1465
  • [2] A first-in-human, open-label, multi-center phase 1 study of TST003, a GREM 1 inhibitor, in subjects with locally advanced or metastatic solid tumors
    Rivera, Ismael Rodriguez
    Shen, Lin
    Kummar, Shivaani
    Barve, Minal
    Germa, Caroline
    Qi, Chuan
    Chen, Lei
    Milata, Jenny
    Yao, Jenny
    Shen, Li
    Zhu, Xuelian
    CANCER RESEARCH, 2024, 84 (06)
  • [3] An Open-Label, First-in-Human, Phase I Trial of Daily Pclx-001
    Sangha, Randeep
    Mackey, John R.
    Sehn, Laurie H.
    Kuruvilla, John
    Weickert, Michael J.
    Berthiaume, Luc G.
    BLOOD, 2021, 138
  • [4] Decitabine in patients with myelodysplastic syndromes: A multi-center, open-label, dose comparison trial
    Liu, Hui
    Jiang, Hao
    Tong, Hongyan
    Xia, Ruixiang
    Yang, Linhua
    Zhao, Hongguo
    Ouyang, Jian
    Bai, Hai
    Sun, Hui
    Hou, Li
    Jiang, Ming
    Zeng, Yun
    Liu, Zhuogang
    Liang, Aibin
    Xie, Yinghua
    Yu, Kang
    Zhai, Zhimin
    Liu, Li
    Jia, Jinsong
    Fu, Rong
    Shao, Zonghong
    CANCER MEDICINE, 2023, 12 (13): : 13885 - 13893
  • [5] A First in Class, Open-Label, First-in-Human, Phase I Trial of Daily Oral Pclx-001
    Sangha, Randeep
    Sehn, Laurie H.
    Jamal, Rahima
    Spratlin, Jennifer
    Kuruvilla, John
    Weickert, Michael J.
    Berthiaume, Luc G.
    Mackey, John R.
    BLOOD, 2022, 140 : 12057 - 12058
  • [6] A phase 1, open-label, first-in-human study of TAS2940 in patients with advanced solid tumors
    Ahnert, Jordi Rodon
    Spigel, David R.
    Kremer, Jill
    Jin, Leah
    Benhadji, Karim Adnane
    Gil, Maciej
    Besse, Benjamin
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [7] An open-label, first-in-human, phase I trial of the safety and efficacy of daily PCLX-001.
    Sangha, Randeep S.
    Sehn, Laurie Helen
    Kuruvilla, John
    Weickert, Michael
    Mackey, John Robert
    Berthiaume, Luc G.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [8] A Phase 2 Multi-center, Open-label, Switch-over Trial to Evaluate the Safety and Efficacy of Abcertin® in Patients with Type 1 Gaucher Disease
    Choi, Jin-Ho
    Lee, Beom Hee
    Ko, Jung Min
    Sohn, Young Bae
    Lee, Jin-Sung
    Kim, Gu-Hwan
    Heo, Sun Hee
    Park, June-Young
    Kim, Yoo-Mi
    Kim, Ja-Hye
    Yoo, Han-Wook
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2015, 30 (04) : 378 - 384
  • [9] Efficacy and safety of paliperidone ER in patients with first episode psychosis: An open-label, prospective, multi-center study
    Chung, Y. -C.
    Park, J. -I.
    Cho, D. -H.
    Hahn, S. -W.
    Han, C.
    Jung, M. H.
    Kim, J. -H.
    Kim, S. -W.
    Lee, K. Y.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2014, 17 : 67 - 67
  • [10] Open-Label, Multi-Center Phase I Dose Escalation Study with Lenalidomide In Patients with Acute Myeloid Leukemia
    Huetter, Marie-Luise
    Fiedler, Walter
    Kuendgen, Andrea
    Krauter, Juergen
    von Lilienfeld-Toal, Marie
    Kayser, Sabine
    Rafler, Heidi
    Doehner, Hartmut
    Schlenk, Richard F.
    BLOOD, 2010, 116 (21) : 1350 - 1351
12345